- Home
- PAVS vs CTMX Comparison
PAVS vs CTMX Comparison
Compare PAVS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CTMX
- Stock Information
- Founded
- PAVS 2004
- CTMX 2008
- Country
- PAVS United States
- CTMX United States
- Employees
- PAVS N/A
- CTMX N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- CTMX Health Care
- Exchange
- PAVS Nasdaq
- CTMX Nasdaq
- Market Cap
- PAVS 49.1M
- CTMX 349.6M
- IPO Year
- PAVS 2019
- CTMX 2015
- Fundamental
- Price
- PAVS $0.77
- CTMX $2.00
- Analyst Decision
- PAVS
- CTMX Strong Buy
- Analyst Count
- PAVS 0
- CTMX 3
- Target Price
- PAVS N/A
- CTMX $5.67
- AVG Volume (30 Days)
- PAVS 144.6K
- CTMX 3.1M
- Earning Date
- PAVS 08-04-2025
- CTMX 11-06-2025
- Dividend Yield
- PAVS N/A
- CTMX N/A
- EPS Growth
- PAVS N/A
- CTMX 263.20
- EPS
- PAVS N/A
- CTMX 0.49
- Revenue
- PAVS $71,542.00
- CTMX $141,100,000.00
- Revenue This Year
- PAVS N/A
- CTMX N/A
- Revenue Next Year
- PAVS N/A
- CTMX N/A
- P/E Ratio
- PAVS N/A
- CTMX $4.27
- Revenue Growth
- PAVS N/A
- CTMX 18.01
- 52 Week Low
- PAVS $0.32
- CTMX $0.40
- 52 Week High
- PAVS $1.50
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- PAVS 47.97
- CTMX 44.39
- Support Level
- PAVS $0.77
- CTMX $2.04
- Resistance Level
- PAVS $0.90
- CTMX $2.16
- Average True Range (ATR)
- PAVS 0.10
- CTMX 0.13
- MACD
- PAVS 0.01
- CTMX 0.01
- Stochastic Oscillator
- PAVS 24.98
- CTMX 9.09
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.